|
1
|
Kanter JE and Bornfeldt KE: Impact of
Diabetes Mellitus. Arterioscler Thromb Vasc Biol. 36:1049–1053.
2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Ashcroft FM and Rorsman P: Diabetes
mellitus and the β cell: The last ten years. Cell. 148:1160–1171.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Wright E Jr, Scism-Bacon JL and Glass LC:
Oxidative stress in type 2 diabetes: The role of fasting and
postprandial glycaemia. Int J Clin Pract. 60:308–314.
2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Oelze M, Schuhmacher S and Daiber A:
Organic nitrates and nitrate resistance in diabetes: The role of
vascular dysfunction and oxidative stress with emphasis on
antioxidant properties of pentaerithrityl tetranitrate. Exp
Diabetes Res. 2010(213176)2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lund E, Güttinger S, Calado A, Dahlberg JE
and Kutay U: Nuclear export of microRNA precursors. Science.
303:95–98. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Han J, Lee Y, Yeom KH, Nam JW, Heo I, Rhee
JK, Sohn SY, Cho Y, Zhang BT and Kim VN: Molecular basis for the
recognition of primary microRNAs by the Drosha-DGCR8 complex. Cell.
125:887–901. 2006.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Flynt AS and Lai EC: Biological principles
of microRNA-mediated regulation: Shared themes amid diversity. Nat
Rev Genet. 9:831–842. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Camussi G, Deregibus MC, Bruno S,
Cantaluppi V and Biancone L: Exosomes/microvesicles as a mechanism
of cell-to-cell communication. Kidney Int. 78:838–848.
2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Wang C, Wan S, Yang T, Niu D, Zhang A,
Yang C, Cai J, Wu J, Song J, Zhang CY, et al: Increased serum
microRNAs are closely associated with the presence of microvascular
complications in type 2 diabetes mellitus. Sci Rep.
6(20032)2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Guo J, Han J, Liu J and Wang S:
MicroRNA-770-5p contributes to podocyte injury via targeting E2F3
in diabetic nephropathy. Braz J Med Biol Res.
53(e9360)2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Li Y, Liang Y, Sang Y, Song X, Zhang H,
Liu Y, Jiang L and Yang Q: miR-770 suppresses the chemo-resistance
and metastasis of triple negative breast cancer via direct
targeting of STMN1. Cell Death Dis. 9(14)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang Z, Yang Y and Zhang X: miR-770
inhibits tumorigenesis and EMT by targeting JMJD6 and regulating
WNT/β-catenin pathway in non-small cell lung cancer. Life Sci.
188:163–171. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Wu WJ, Shi J, Hu G, Yu X, Lu H, Yang ML,
Liu B and Wu ZX: Wnt/β-catenin signaling inhibits FBXW7 expression
by upregulation of microRNA-770 in hepatocellular carcinoma. Tumour
Biol. 37:6045–6051. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Guo W, Dong Z, Liu S, Qiao Y, Kuang G, Guo
Y, Shen S and Liang J: Promoter hypermethylation-mediated
downregulation of miR-770 and its host gene MEG3, a long non-coding
RNA, in the development of gastric cardia adenocarcinoma. Mol
Carcinog. 56:1924–1934. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Zhao H, Yu X, Ding Y, Zhao J, Wang G, Wu
X, Jiang J, Peng C, Guo GZ and Cui S: miR-770-5p inhibits cisplatin
chemoresistance in human ovarian cancer by targeting ERCC2.
Oncotarget. 7:53254–53268. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang L and Li H: miR-770-5p facilitates
podocyte apoptosis and inflammation in diabetic nephropathy by
targeting TIMP3. Biosci Rep. 40(BSR20193653)2020.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhang SZ, Qiu XJ, Dong SS, Zhou LN, Zhu Y,
Wang MD and Jin LW: MicroRNA-770-5p is involved in the development
of diabetic nephropathy through regulating podocyte apoptosis by
targeting TP53 regulated inhibitor of apoptosis 1. Eur Rev Med
Pharmacol Sci. 23:1248–1256. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Zhang YL and Chen XQ: Dysregulation of
microRNA-770-5p influences pancreatic-β-cell function by targeting
TP53 regulated inhibitor of apoptosis 1 in gestational diabetes
mellitus. Eur Rev Med Pharmacol Sci. 24:793–801. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Böni-Schnetzler M and Meier DT: Islet
inflammation in type 2 diabetes. Semin Immunopathol. 41:501–513.
2019.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Mezza T, Cinti F, Cefalo CMA, Pontecorvi
A, Kulkarni RN and Giaccari A: β-Cell Fate in Human Insulin
Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.
Diabetes. 68:1121–1129. 2019.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: Diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kanellis J, Watanabe S, Li JH, Kang DH, Li
P, Nakagawa T, Wamsley A, Sheikh-Hamad D, Lan HY, Feng L, et al:
Uric acid stimulates monocyte chemoattractant protein-1 production
in vascular smooth muscle cells via mitogen-activated protein
kinase and cyclooxygenase-2. Hypertension. 41:1287–1293.
2003.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Δ Δ C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Townsend PA, Cutress RI, Sharp A, Brimmell
M and Packham G: BAG-1: A multifunctional regulator of cell growth
and survival. Biochim Biophys Acta. 1603:83–98. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bruchmann A, Roller C, Walther TV, Schäfer
G, Lehmusvaara S, Visakorpi T, Klocker H, Cato AC and Maddalo D:
Bcl-2 associated athanogene 5 (Bag5) is overexpressed in prostate
cancer and inhibits ER-stress induced apoptosis. BMC Cancer.
13(96)2013.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Guo K, Li L, Yin G, Zi X and Liu L: Bag5
protects neuronal cells from amyloid β-induced cell death. J Mol
Neurosci. 55:815–820. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Gupta MK, Tahrir FG, Knezevic T, White MK,
Gordon J, Cheung JY, Khalili K and Feldman AM: GRP78 Interacting
Partner Bag5 Responds to ER Stress and Protects Cardiomyocytes From
ER Stress-Induced Apoptosis. J Cell Biochem. 117:1813–1821.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wang X, Guo J, Fei E, Mu Y, He S, Che X,
Tan J, Xia K, Zhang Z, Wang G, et al: BAG5 protects against
mitochondrial oxidative damage through regulating PINK1
degradation. PLoS One. 9(e86276)2014.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xue M and Jackson CJ: Activated protein C
and its potential applications in prevention of islet β-cell damage
and diabetes. Vitam Horm. 95:323–363. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu Q and Axtell MJ: Quantitating plant
microRNA-mediated target repression using a dual-luciferase
transient expression system. Methods Mol Biol. 1284:287–303.
2015.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Wang Z, Zhu Z, Lin Z, Luo Y, Liang Z,
Zhang C, Chen J and Peng P: miR-429 suppresses cell proliferation,
migration and invasion in nasopharyngeal carcinoma by
downregulation of TLN1. Cancer Cell Int. 19(115)2019.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Wild S, Roglic G, Green A, Sicree R and
King H: Global prevalence of diabetes: Estimates for the year 2000
and projections for 2030. Diabetes Care. 27:1047–1053.
2004.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Tiwari J, Gupta G, de Jesus Andreoli Pinto
T, Sharma R, Pabreja K, Matta Y, Arora N, Mishra A, Sharma R and
Dua K: Role of microRNAs (miRNAs) in the pathophysiology of
diabetes mellitus. Panminerva Med. 60:25–28. 2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhang Y, Sun X, Icli B and Feinberg MW:
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease:
Novel Targets for Therapy. Endocr Rev. 38:145–168. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Behradmanesh S, Horestani MK, Baradaran A
and Nasri H: Association of serum uric acid with proteinuria in
type 2 diabetic patients. J Res Med Sci. 18:44–46. 2013.PubMed/NCBI
|
|
36
|
Ye X, Cao Y, Gao F, Yang Q, Zhang Q, Fu X,
Li J and Xue Y: Elevated serum uric acid levels are independent
risk factors for diabetic foot ulcer in female Chinese patients
with type 2 diabetes. J Diabetes. 6:42–47. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Viazzi F, Piscitelli P, Giorda C, Ceriello
A, Genovese S, Russo G, Guida P, Fioretto P, De Cosmo S and
Pontremoli R: AMD-Annals Study Group. Metabolic syndrome, serum
uric acid and renal risk in patients with T2D. PLoS One.
12(e0176058)2017.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Ding Y, Shi X, Shuai X, Xu Y, Liu Y, Liang
X, Wei D and Su D: Luteolin prevents uric acid-induced pancreatic
β-cell dysfunction. J Biomed Res. 28:292–298. 2014.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Adeyemo AA, Zaghloul NA, Chen G, Doumatey
AP, Leitch CC, Hostelley TL, Nesmith JE, Zhou J, Bentley AR,
Shriner D, et al: South Africa Zulu Type 2 Diabetes Case-Control
Study: ZRANB3 is an African-specific type 2 diabetes locus
associated with beta-cell mass and insulin response. Nat Commun.
10(3195)2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Fornari TA, Donate PB, Assis AF, Macedo C,
Sakamoto-Hojo ET, Donadi EA and Passos GA: Comprehensive Survey of
miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are
Posttranscriptionally Controlled in Pancreas Infiltrating T
Lymphocytes of Non-Obese Diabetic (NOD) Mice. PLoS One.
10(e0142688)2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Gerber PA and Rutter GA: The Role of
Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in
Diabetes Mellitus. Antioxid Redox Signal. 26:501–518.
2017.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Fu Z, Gilbert ER and Liu D: Regulation of
insulin synthesis and secretion and pancreatic Beta-cell
dysfunction in diabetes. Curr Diabetes Rev. 9:25–53.
2013.PubMed/NCBI
|
|
44
|
Grieco FA, Sebastiani G, Juan-Mateu J,
Villate O, Marroqui L, Ladrière L, Tugay K, Regazzi R, Bugliani M,
Marchetti P, et al: MicroRNAs miR-23a-3p, miR-23b-3p, and
miR-149-5p Regulate the Expression of Proapoptotic BH3-Only
Proteins DP5 and PUMA in Human Pancreatic β-Cells. Diabetes.
66:100–112. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhao X, Mohan R, Özcan S and Tang X:
MicroRNA-30d induces insulin transcription factor MafA and insulin
production by targeting mitogen-activated protein 4 kinase 4
(MAP4K4) in pancreatic β-cells. J Biol Chem. 287:31155–31164.
2012.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Schroeder IS, Kania G, Blyszczuk P and
Wobus AM: Insulin-producing cells. Methods Enzymol. 418:315–333.
2006.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Ramzy A, Mojibian M and Kieffer TJ:
Insulin-Deficient Mouse β-Cells Do Not Fully Maturebut Can Be
Remedied Through Insulin Replacementby Islet Transplantation.
Endocrinology. 159:83–102. 2018.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Melkman-Zehavi T, Oren R, Kredo-Russo S,
Shapira T, Mandelbaum AD, Rivkin N, Nir T, Lennox KA, Behlke MA,
Dor Y, et al: miRNAs control insulin content in pancreatic β-cells
via downregulation of transcriptional repressors. EMBO J.
30:835–845. 2011.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Guay C and Regazzi R: MicroRNAs and the
functional β cell mass: For better or worse. Diabetes Metab.
41:369–377. 2015.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Poy MN, Eliasson L, Krutzfeldt J, Kuwajima
S, Ma X, Macdonald PE, Pfeffer S, Tuschl T, Rajewsky N, Rorsman P,
et al: A pancreatic islet-specific microRNA regulates insulin
secretion. Nature. 432:226–230. 2004.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Fred RG, Mehrabi S, Adams CM and Welsh N:
PTB and TIAR binding to insulin mRNA 3'- and 5'UTRs; implications
for insulin biosynthesis and messenger stability. Heliyon.
2(e00159)2016.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Setyowati Karolina D, Sepramaniam S, Tan
HZ, Armugam A and Jeyaseelan K: miR-25 and miR-92a regulate insulin
I biosynthesis in rats. RNA Biol. 10:1365–1378. 2013.PubMed/NCBI View Article : Google Scholar
|
